AMBUJACEM - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.1
| Stock Code | AMBUJACEM | Market Cap | 1,14,289 Cr. | Current Price | 460 ₹ | High / Low | 625 ₹ |
| Stock P/E | 29.5 | Book Value | 213 ₹ | Dividend Yield | 0.44 % | ROCE | 3.25 % |
| ROE | 7.67 % | Face Value | 2.00 ₹ | DMA 50 | 451 ₹ | DMA 200 | 503 ₹ |
| Chg in FII Hold | 0.03 % | Chg in DII Hold | -0.02 % | PAT Qtr | 1,742 Cr. | PAT Prev Qtr | -59.2 Cr. |
| RSI | 59.7 | MACD | -0.27 | Volume | 45,16,243 | Avg Vol 1Wk | 36,14,829 |
| Low price | 394 ₹ | High price | 625 ₹ | PEG Ratio | 2.21 | Debt to equity | 0.02 |
| 52w Index | 28.6 % | Qtr Profit Var | 214 % | EPS | 14.4 ₹ | Industry PE | 29.0 |
📊 Chart Patterns: AMBUJACEM is forming higher lows with resistance near ₹470–₹480 and support around ₹450 (50 DMA). Trendlines suggest bullish continuation after recent recovery.
📈 Moving Averages: Current price (₹460) is above 50 DMA (₹451) but below 200 DMA (₹503), showing short-term strength but medium-term resistance.
📊 RSI: At 59.7, RSI indicates positive momentum, approaching overbought territory.
📉 MACD: Slightly negative at -0.27, showing weak crossover and mixed signals.
📊 Bollinger Bands: Price is mid-to-upper band, suggesting potential expansion toward ₹470–₹480.
📊 Volume Trends: Current volume (45,16,243) is above 1-week average (36,14,829), showing strong participation and accumulation.
🚀 Momentum Signals: Bullish bias with potential breakout if price sustains above ₹470.
🎯 Entry Zone: ₹450–₹460 (near 50 DMA support).
🎯 Exit Zone: ₹470–₹480 (resistance zone and upper Bollinger band).
📌 Trend Status: Trending upward with consolidation near resistance.
Positive
- Quarterly PAT turnaround (₹1,742 Cr. vs -₹59.2 Cr.) highlights strong recovery.
- EPS at ₹14.4 supports earnings visibility.
- Low debt-to-equity ratio (0.02) ensures financial stability.
- FII holdings increased (+0.03%), showing marginal foreign investor confidence.
Limitation
- Stock trading below 200 DMA (₹503) reflects medium-term weakness.
- ROCE (3.25%) and ROE (7.67%) remain weak, showing inefficient capital use.
- PEG ratio (2.21) suggests moderately expensive growth prospects.
Company Negative News
- DII holdings decreased (-0.02%), showing reduced domestic institutional support.
Company Positive News
- Quarterly profit variation (+214%) highlights strong operational turnaround.
- Dividend yield of 0.44% adds shareholder value.
Industry
- Industry PE at 29.0 is aligned with AMBUJACEM’s PE (29.5), suggesting fair valuation.
- Cement sector benefiting from infrastructure growth and housing demand.
Conclusion
AMBUJACEM shows bullish technical signals supported by strong profit turnaround and volume participation. Entry near ₹450–₹460 offers favorable risk-reward with exit targets around ₹470–₹480. Trend remains upward but requires monitoring of medium-term resistance at 200 DMA for sustained breakout.
This can be integrated into a cement sector breakout template with benchmarking overlays, so you can compare AMBUJACEM against peers like ULTRACEMCO and RAMCOCEM for relative strength.